#Enoxaparin

[csmeaner]

Bitch, you ain't slick. toyhou se(/~)forums(/)13(.)adoption-center(/)323531(.)-voided-nicooo-sr-mig-for-sale-urgent-

.https://toyhou.se/~forums/13.adoption-center/323531.-voided-nicooo-sr-mig-for-sale-urgent-

that's a fuckton of hoops you've gone through just to be doing the same lame song and dance. in case you're not familiar ex-tomoyoki owner tsuyeu, then enaxporin, had voided an SR nicooo/casin0s made mignyan to sell it for 2500 fucking usd and selling their own design /in dainty bundles to jack up the price and apparently when people caught on started changing their name when they were selling the exact same fucking thing. now they've made a whole new account apparently just to sell this horcrux it's the only fucking thing on the description and the account was made yesterday fucking pathetic

made yesterday and invited by a bunch of 0's

huh i wonder who those zeros actually is

the stupid mig even has the same description copypasted

[phonemantra-blog]

The Enigmatic Side Effects of Lovenox: A Comprehensive Guide Lovenox is a commonly prescribed medication used for its anticoagulant properties. It is often prescribed to prevent blood clots in individuals at risk due to various medical conditions. Understanding the potential side effects of Lovenox is crucial for both healthcare professionals and patients to ensure safe and effective use of the medication. [caption id="attachment_59381" align="aligncenter" width="2400"] lovenox side effects[/caption] Lovenox, also known as enoxaparin, works by inhibiting certain clotting factors in the blood, thereby preventing the formation of blood clots. While it is an effective medication, it is essential to be aware of the possible side effects that may occur during Lovenox therapy. This comprehensive guide aims to provide an organized overview of the side effects associated with Lovenox. By categorizing them into common and rare but serious side effects, readers will gain a better understanding of what to expect and when to seek medical attention. Common Side Effects Common side effects of Lovenox may include: Gastrointestinal Disturbances Gastrointestinal disturbances are among the common side effects of Lovenox. These may include: Nausea and vomiting Diarrhea or constipation Abdominal pain or discomfort Injection Site Reactions Injection site reactions are another common side effect of Lovenox. These reactions may manifest as: Redness, swelling, or itching at the injection site Bruising or hematoma formation Pain or tenderness Hemorrhage and Bruising Lovenox's anticoagulant properties can lead to an increased risk of bleeding and bruising. Common symptoms may include: Easy bruising or bleeding Prolonged bleeding from minor cuts or injuries Blood in urine or stool Headache and Dizziness Headache and dizziness are potential side effects that some individuals may experience while taking Lovenox. These symptoms can vary in intensity and may require management strategies such as: Taking over-the-counter pain relievers as directed Resting and avoiding strenuous activities Ensuring proper hydration Rare but Serious Side Effects While rare, there are some serious side effects associated with Lovenox that require immediate medical attention. These include: Allergic Reactions Some individuals may experience allergic reactions to Lovenox. These reactions can range from mild to severe, with the potential for anaphylaxis, a life-threatening allergic response. It is important to be aware of the following symptoms and take immediate action: Difficulty breathing Swelling of the face, lips, or throat Rash or hives Chest tightness or palpitations If any of these symptoms occur, it is crucial to seek immediate medical assistance. Thrombocytopenia Thrombocytopenia, or low platelet count, is a rare but serious side effect of Lovenox. It can lead to an increased risk of bleeding. Signs and symptoms of thrombocytopenia may include: Unexplained or excessive bruising Prolonged bleeding from minor cuts or injuries Nosebleeds or bleeding gums Unusually heavy or prolonged menstrual periods If any of these symptoms occur, it is important to consult a healthcare professional for further evaluation and potential treatment options. Osteoporosis and Bone Fractures Long-term use of Lovenox may increase the risk of developing osteoporosis, a condition characterized by weakened bones. This can potentially lead to an increased risk of bone fractures. To maintain bone health while on Lovenox, consider the following preventive measures: Ensure an adequate intake of calcium and vitamin D Engage in weight-bearing exercises Avoid smoking and excessive alcohol consumption It is also important to discuss any concerns about bone health with a healthcare professional. Spinal/Epidural Hematoma A rare but serious complication associated with Lovenox use is the development of a spinal/epidural hematoma, particularly in individuals undergoing spinal procedures. Symptoms of a spinal/epidural hematoma may include: Severe back pain Numbness or weakness in the legs Loss of bladder or bowel control Individuals on Lovenox should take precautions and inform their healthcare provider if they are scheduled for a spinal procedure to assess the potential risks and benefits. FAQs - Frequently Asked Questions What is the recommended dosage of Lovenox? The recommended dosage of Lovenox can vary depending on the specific medical condition being treated. It is important to follow the prescribed dosage instructions provided by the healthcare professional. Can Lovenox be used during pregnancy? Lovenox can be used during pregnancy, but it should be done under the guidance and supervision of a healthcare professional. The potential risks and benefits should be carefully evaluated for each individual case. Are there any drug interactions to be aware of? Yes, Lovenox can interact with certain medications. It is important to inform the healthcare professional about all the medications, including prescription, over-the-counter, and herbal supplements, being taken to avoid potential interactions. How long does it take for Lovenox to start working? Lovenox typically starts working within a few hours of administration. However, the exact onset of action may vary depending on the individual and the specific medical condition being treated. Can Lovenox cause hair loss? Hair loss is not a commonly reported side effect of Lovenox. If you experience any unusual hair loss while taking Lovenox, it is important to consult a healthcare professional to determine the underlying cause. What should I do if I miss a dose of Lovenox? If you miss a dose of Lovenox, it is important to take it as soon as you remember. However, if it is close to thetime for your next scheduled dose, it is best to skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one. Is it safe to consume alcohol while on Lovenox? It is generally safe to consume alcohol in moderation while on Lovenox. However, it is important to consult with a healthcare professional to ensure that there are no specific contraindications or interactions with any other medications you may be taking. Can Lovenox be used in children? Lovenox can be used in children, but the dosage and administration should be determined by a pediatrician or healthcare professional experienced in pediatric anticoagulation therapy. The safety and efficacy of Lovenox in children may vary depending on the specific medical condition and age of the child. Are there any dietary restrictions while on Lovenox? There are no specific dietary restrictions associated with Lovenox use. However, it is important to maintain a balanced and healthy diet to support overall health and well-being. What are the alternatives to Lovenox? There are several alternatives to Lovenox available, including other anticoagulant medications such as heparin or warfarin. The choice of alternative medication will depend on various factors, including the specific medical condition and individual patient characteristics. It is important to consult with a healthcare professional to determine the most appropriate alternative for your specific needs. Conclusion Understanding the potential side effects of Lovenox is crucial for safe and effective use of the medication. By categorizing the side effects into common and rare but serious categories, this comprehensive guide provides a valuable resource for both healthcare professionals and patients. It is important to remember that everyone's response to medication can vary, and not all individuals will experience the same side effects. If you have any concerns or questions about Lovenox or its side effects, it is always best to consult with a healthcare professional who can provide personalized guidance based on your specific medical history and needs. Ultimately, the benefits of Lovenox therapy in preventing blood clots and managing certain medical conditions should be carefully weighed against the potential risks of side effects. By staying informed and working closely with your healthcare team, you can make well-informed decisions about your treatment plan.

[venusremediespharma]

Are you looking for a top enoxaparin manufacturer in Baddi? If so, check out this blog which is explaining venus remedies. Venus Remedies is a leading manufacturer of enoxaparin and other pharmaceutical products. They have a state-of-the-art manufacturing facility in Baddi, India and are committed to providing the highest quality products to their customers.

Check out: https://venusremedies.com/blog/top-enoxaparin-manufacturer-in-baddi

[chemanalysta]

Enoxaparin Sodium Prices in The Global Market Online

Enoxaparin Sodium Prices in North America showed a stable trend during the 4th quarter of 2022. Enoxaparin Sodium imports were halted during the first week of October due to China's Golden Week holiday. Given the substantial product inventories, domestic suppliers were able to meet the demand for the majority of the quarter, and up until this point, offtakes in the end-user industries continued to be normal. The unanticipated increase in Covid cases in China caused a pattern shift in the market for Enoxaparin Sodium at the conclusion of the quarter. The broken supply chain did, however, gradually heal as the economy expanded, and there was a major decrease in port backlog in December.

[lonesome-king23]

I just failed my math test gonna go cry now

[akashpawar0412]

Enoxaparin Sodium Injection Market Value Report Forecast 2022-2030

Global Enoxaparin sodium market is estimated to be worth USD 2904.7 Million in 2020 and is projected to grow at a CAGR of 8.20% between 2017 to 2028. The study has considered the base year as 2020, which estimates the market size of market and the forecast period is 2021 to 2028. The report analyzes and forecasts the market size, in terms of value (USD Million), for the market. The report segments the market and forecasts its size, by drugs type, by application, by sales channels and region/country. 

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/4/enoxaparin-sodium-injection-market

Enoxaparin sodium is an anticoagulant heparin with a low molecular weight drug (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to treat and prevent blood clots during pregnancy and after certain types of surgery. Pulmonary embolism occurs when blood clots move through the lungs and get stuck in the blood vessels of lungs. This medication is prescribed for a period of time after knee or hip replacement surgery, as well as in some cases of abdominal surgery and also in the event of a major illness. Moreover, enoxaparin sodium is used in those with acute coronary syndrome (ACS) and heart attack. It is injected into a vein or just beneath the skin. Bleeding, fever, and leg swelling are all common adverse effects. Bleeding might be dangerous, especially if an individual is having a spinal tap.

Increase in number of Food and Drug Administration approval drugs and surge in the geriatric population are some factors, which boost the market growth. Rise in awareness for the treatment of several cardiovascular disease fuels the market growth. In addition, increase in healthcare expenditure, rise in research & development activities conducted by many pharmaceutical companies, launches of novel developed drug in market are some factors which contribute toward the enoxaparin sodium market growth.

The enoxaparin sodium market size is expected to be valued at USD 5334.8 million by 2028. The enoxaparin sodium market is segmented into type, application, and sales channel. Based on the type, enoxaparin sodium market is segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, and others. Based on the application, enoxaparin sodium market is segmented into hospitals, clinics, and others. Based on the sales channel, enoxaparin sodium market is bifurcated into direct channel and indirect channel.

This report provides detailed historical analysis of global market for Enoxaparin Sodium Injection from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Enoxaparin Sodium Injection market.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

Market Segment Analysis:

Leading players of Enoxaparin Sodium Injection including:

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

The information for each competitor/Company Profile includes:

Company Overview

Business Strategy

Key Product Offerings

Financial Performance

Key Performance Indicators

Risk Analysis

Recent Development

Regional Presence

SWOT Analysis

Market split by Type, can be divided into:

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

Market split by Application, can be divided into:

Hospital

Clinic

Others

Market split by Sales Channel, can be divided into:

Direct Channel

Distribution Channel

Enoxaparin is commonly used in cardiac patients. As with all low molecular weight heparins, (LMWHs) the drug is easy to administer subcutaneously as compared with intravenous infusion of unfractionated heparin. Unlike other LMWHs, enoxaparin has been shown to be superior to intravenous unfractionated heparin in patients with non-ST elevation and ST elevation acute coronary syndromes (ACS), and a comparable agent in patients undergoing elective percutaneous coronary intervention (PCI) with decreased bleeding. However, elective PCI in patients without ACS is currently not in the enoxaparin label. It primarily inhibits factors Xa and IIa with a greater effect on factor Xa. Enoxaparin is renally cleared and a dose adjustment by 50% reduction is recommended for patients with creatinine clearance below 30 ml/min. In patients aged 75 years or older undergoing fibrinolysis, it is recommended that the intravenous bolus of 30 mg be omitted and that only 75% of the usually recommended dose of 1 mg/kg subcutaneously twice-daily be administered.

Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.

The commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global enoxaparin sodium market.

Market segment by Region/Country including:

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, South America and Middle East and Africa. In 2020, Europe is anticipated to dominate the Enoxaparin sodium market with a market revenue of 1,224.32 USD Million with a registered CAGR of 8.53%.

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America (Brazil, Argentina and Colombia etc.)

Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

The scope of the Enoxaparin sodium market report includes a detailed study of Enoxaparin sodium and regional markets for Enoxaparin sodium industry. The Enoxaparin sodium market report is segmented by product type, by application and by region. It reveals market situation and future forecast. The study also covers the significant data presented with the help of graphs and tables. The Enoxaparin sodium market report covers information regarding competitive outlook including the company profiles of the key participants operating in the Enoxaparin sodium market. Key players profiled in the report include Sanodz, Winthrop U.S., Sanofi, Themis Medicare Limited, Actavis Pharma Company, Shenzhen Techdow Pharmaceutical and Others

• To define and describe the Enoxaparin sodium market segmented by drug type, by application, by sales channel and by geographic region. 

• To estimate and forecast the market size for various segments with regard to regions: North America, Europe, Asia Pacific, South America and Middle East and Africa.

• To profile key players and comprehensively analyze their market position in terms of core competencies.

• To analyze the markets situation with regard to industry trends, prospects, and contribution  to the total market by identifying the high-growth segments of the Enoxaparin sodium market and provide the competitive landscape.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2030 & Sales with a thorough analysis of the markets competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2030. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase:

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Get the Complete Report & TOC at https://www.intelmarketresearch.com/life-sciences/4/enoxaparin-sodium-injection-market

CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 Email: help@intelmarketresearch.com Follow Us On linkedin :- https://www.linkedin.com/company/intel-market-research

[vijayanger12]

The global Enoxaparin Sodium market size is estimated to be worth US$ 3318.7 million in 2022 and is forecast to a readjusted size of US$ 5354.7 million by 2030 with a CAGR of 8.3% during the review period.

[csmeaner]

Omfg Tsuyeu, just sell the mig at a loss or fuck off. Wasn't that mig $1500 originally tops? That's still a lot of fucking money. Try that with a decent pay plan offered and maybe someone will put you out of your misery.

post related

people staying in cs just so they don't eat a loss when being in cs is a loss already

[squidresearchlabs]

may i request npts based on being a mad scientist who's also a cute girl? tysm!!

ooh i love this !!

names

cell , marrow , enoxaparin , molly , medusa , marina , toxin , hazard , lobotelle , plasticulla , lymphoid , foggy , patchy , elara , jupiter , lumen , ester , staurozoa , mandible/mandi , neuralgia , positron , posy , spore , pathogenica , gamma , violet , millie , clumselle , hatchet , comet , opaque , pearl , decora , gorgon

pronouns

bone/bones , x-ray/x-rays , needle/needles , spill/spills , mask/masks , elec/electric , zip/zaps , tissue/tissues , patch/patches , mutate/mutates , mutant/mutants , radio/radiographs , rad/radiations , sick/sickness , poi/poisons , magnet/magnets , oops/whoops , cute/cutes , beam/beams

titles

(prn) who puts glitter in (prns) concoctions , the one in the hypno-glasses , (prn) who performs biopsies , (prn) who creates monstrosities , the cackling one , (prn) who is wicked , the dizzying one , (name) and (prns) favorite experiment , the one with the sparkly needle , the one who coughs up blood/other , (prn) who has specific favorite moons , the radiologist , (prn) who is a parasite , (prn) who created new illnesses , the world's favorite scientist , the one with the pink slime monsters , (prn) who calls (prns) creations (prns) children , the one covered in glitters and sparkles

i had so much fun with this ... a lot of these are cytology based im sorry if you wanted a different field as a focus ! still , i hope these are good !! thank you for requesting !!

[mcatmemoranda]

Anticoagulation Lecture 6/21/23

Factor Xa inhibitors = rivaroxaban, apixaban (Eliquis)

Direct thrombin inhibitor = dabigatran

Vitamin K inhibitor = warfarin

Apixaban has the lowest bleeding risk compared to the other Direct Oral Anticoagulants (DOACs); avoid in pts with BMI greater than or equal to 40 or weight more than 120 kg. Avoid dual inhibitors or inducers of CYP3A4 and P-gp.

VTE/PE tx = 10mg bid x7 days, then 5 mg bid

AFib = 5 mg bid (reduce to 2.5 mg bid if Cr greater than or equal to 1.5 or weight less than 60 kg or age greater than 80

Rivaroxaban (Xarelto) = once daily dosing compared to Eliquis

VTE/PE: 15 mg bid x21 days; then 20 mg qd

AFib: 20 mg qd with food to increase absorption

PAD/CAD: 2.5 mg bid (+antiplatelets if at increased risk)

Avoid with CYP3A4 inhibitors or inducers and P-gp

Edoxaban (Savaysa) – not used in pts with CrCl greater than 95

VTE/PE = parenteral anticoagulation for 5-10 days, then PO

VTE/PE/AFib = 60 mg qd

Does not have reversal agent like other DOACs do (which are reversed with Kcentra or andexanet)

Dabigatran (Pradaxa)

AFib: 150 mg bid; consider 110 mg bid if bleeding risk

VTE/PE: 5 days IV, then 150 mg bid

VTE ppx after THA/TKA: initial 110 mg once, then 220 mg qd x10-35 days

5-10 day bridge required for PE/VTE

Caution in pts greater than 75 years due to increased bleeding risk

Has own reversal agent (praxbind; idarucizumab)

C/I in pts with prosthetic heart valve

Store in original bottle and discard if unused after 4 months

Eliquis and Xarelto can be crushed and given via feeding tubes.

Warfarin (Coumadin)

Dosing is pt specific. Goal INR is 2-3. (2.5-3.5 if mechanical mitral valve).

Slow onset; slow time to steady state means dose taken today may not be reflected in INR for several days (2-4 days).

So many drug-drug interactions!

Metabolized by CYP pathways

Vitamin K antagonist

Dosing: recommend taking at night because INR is taken during the day, makes it easier to adjust dose.

Warfarin’s therapeutic steady state is based on half-lives of clotting factors. At least 5 days of consecutive warfarin needed for pt to be fully anticoagulated (this is why you use heparin until they get to this point).

Usually start with 5 mg qd. If bleeding risk, start with 2.5 mg qd. For obese pts or otherwise healthy/young can start with 7.5 mg qd. You go to maintenance protocol on 7th day.

Pts on VTE/PE tx are not anticoagulated the first 5 days, so use heparin IV or LMWH outpt. Once anticoagulated x24 hours, d/c heparin.

Start with 5 mg warfarin for first 3 days, then follow up with warfarin clinic on day 4. Typically, pt goes for weekly INRs. Then when at goal INR for 2 weeks, can spread out how often they f/u on their INR levels. Eventually they can go q6-8 weeks to check INR level.

VTE/PE – always bridge

AFib – risk assess to see whether heparin bridging is needed (assess bleeding risk [HASBLED]; CHA2DS2VASc for thrombotic risk).

Every 10 years, the dosing needed will decrease by 10%, so as pts age, the dose of warfarin needed will decrease.

DOACs = no INR monitoring, no dietary interactions, lower rates of bleeding, limited availability of reversal agent; contraindicated in pts with mechanical heart valves

AFib – AC (anticoagulate) indefinitely

1st VTE or PE that is provoked – AC for 3 months

1st episode of VTE/PE in setting of cancer – 3 months of AC (LMWH is better than DOAC or warfarin--new research shows DOAC may actually be more effective, so can use DOAC now; LMWH not preferred)

1st episode of VTE/PE unprovoked (no idea what caused it) – AC more than or equal to 3 months

2nd VTE – AC indefinitely

Heparin reversal – protamine (max dose is 50 mg), to reverse enoxaparin, give 1 mg protamine for each 1 mg of Lovenox

Warfarin reversal – vit K; 4 factor prothrombin compex (KCentra); FFP (if KCentra not available); KCentra is for life-threatening bleeding or if pt needs surgery for life-threatening condition

Apixaban/Rivaroxaban reversal – Kcentra (life threatening bleed or need emergency surgery; has thrombotic risk); FFP (Fresh Frozen Plasma); Andexanet Alfa. KCentra can cause clotting in 5% of pts; don’t give if you don’t need to.

Dabigatran reversal – idarucizumab (Praxbind); dosed as 5 g IV given 2.5 mg no more than 15 minutes apart)

Heparin lasts 2 hours

LMWH is preferred in pts who are pregnant (avoid warfarin). ESRD on dialysis – warfarin or Eliquis (avoid Xarelto). Obese pts – DOACs or warfarin. Cancer – use LMWH; recent study shows Eliquis is equal to or superior to LMWH in cancer pts who need anticoagulation.

Pregnancy = lovenox better, doesn’t cross placenta; UFH (unfractionated heparin) is an alternative in pts with poor renal function.

Stop heparin gtt and give Eliquis now or give 2 hours after stopping heparin gtt. Give loading dose Eliquis even if the pt was on heparin gtt.

[bluewindfall]

3 good things

Switched a patient's heparin to enoxaparin because his renal function is trending up now :) so he doesn't have to get poked as many times!

Got to leave rotation a little early today

Saw some pretty flowers growing near my dorm

[chemanalysta]

In Q4 of 2022, Enoxaparin Sodium Prices in the Asia Pacific region during the fourth quarter of 2022 were stable. From October to December, FOB Shenzhen prices slightly decreased in China, going from $24955000 per MT to $24985000 per MT. Due to the closure of manufacturing facilities for the Golden Week, the first week of October saw a steady fall in Enoxaparin Sodium orders for China's API market. It was challenging for the market to catch up to the slight growth seen in some downstream businesses because Chinese traders had to deal with various conflicting signals after a one-week break, but strong demand kept the market afloat. Chinese suppliers and producers were able to meet the entire quarter's demand thanks to ample supplies there. The administration amended its zero-Covid rules in response to criticism and significant unrest in the nation in December, leaving it vulnerable again.

[mnnour20]

هو

إكليل الجبل أو حصى البان أو ندى البحر أو قِرْمانا هي عشبةٌ خشبية دائمة الخُضرة تنتمي إلى العائلة الشفوية «عائلة النعناع». لها أوراق إبرية وأزهارها بيضاء، زهرية، بنفسجية، أو زرقاء، ويرجع أصلها إلى منطقة حوض البحر المتوسط

أضرار عشبة حصى البان

توجد عشبة حصى البان الخام على شكل أوراق، كما يتم تحضير مستخلصاتها على شكل مسحوق أو زيت عطري، وقد يؤدي تناول أوراقها بكثرة أو العلاج بأحد مستخلصاتها إلى حدوث الأضرار الآتية:

الإضرار بالحامل

قد تؤثر عشبة حصى البان على الرحم وتسبب الإجهاض، كما أنه لا توجد أدلة كافية حول أمان استخدامها لدى المرضعات.

منع انغراس البويضة في الرحم

هناك دراسة تشير إلى أن عشبة حصى البان قد تمنع انغراس البويضة في الرحم بعد الإخصاب، إلا أنها قد لا تضر في حال تم الإنغراس قبل تناولها. ولكن عمومًا لا يُنصح بتناولها بكثرة خلال الحمل أو التخطيط للحمل.

زيادة خطر النزيف

قد تزيد عشبة حصى البان من خطر حدوث النزيف لدى المرضى الذين يعانون من اضطرابات تخثر الدم، لذا يجب الحذر عند تناولها لدى هذه الفئة، كما أنها تزيد من نزيف الرحم خلال فترة الدورة الشهرية.

حدوث رد فعل تحسسي

قد تُسبب هذه العشبة حساسية لدى بعض الأجسام بغض النظر عن الكمية المتناولة خصوصًا لدى من يعانون من حساسية من دواء حمض الأسيتلساليسالك (Acetylsalicylic acid)، بسبب احتواءها على مادة كيميائية مشابهة لمادة الساليسليت (Salicylate).

زيادة خطر حدوث التشنجات

من المحتمل أن تزيد من خطر حدوث التشنجات لدى من يعانون من الصرع أو أي أمراض أخرى تسبب التشنجات، ويعود ذلك لاحتوائها على مركبات كيتون المنوتروبين (Monoterpene ketones).

أضرار أخرى لعشبة حصى البان

قد يرافق تناول زيت حصى البان المركز أو كميات كبيرة من أوراقه أعراض جانبية، مثل:

تهيج في الكلى أو الأمعاء أو المعدة.

الاستفراغ.

احمرار الجلد

زيادة حساسية الجلد للشمس

الغيبوبة

التداخلات الدوائية لعشبة حصى البان

من الأضرار المحتملة لعشبة حصى البان هو تداخلها مع العديد من الأدوية مثل

الأدوية المضادة للتخثر أو المضادة لتجمع الصفائح.

مثل

حمض الأسيتيل ساليسيليك (Acetylsalicylic acid).

الكلوبيدوجريل (Clopidogrel).

الأيبوبرفين (Ibuprofen).

الإينوكسابارين (Enoxaparin).

2. الأدوية التي يتم استقلابها عن طريق إنزيم الكبد (CYP1A1)

مثل: الثيوفيلين (Theophylline).

3. الأدوية التي يتم استقلابها عن طريق إنزيم الكبد (CYP1A2)

مثل: الأوندانسيترون (Ondansetron)، والأولانزابين (Olanzapine).

فوائد عشبة حصى البان

عدا عن أضرار عشبة حصى البان، هناك العديد من فوائدها المحتملة في حال تم استخدامها بكميات مناسبة تحت إشراف الطبيب، إليك أهم هذه الفوائد:

تقوية المناعة

تحتوي عشبة حصى البان على مركبات مضادة للأكسدة ومضادة للالتهاب، لذا فهي تساعد في تعزيز المناعة والتخلص من الجذور الحرة.

تحسين عملية الهضم

يُعتقد أن عشبة حصى البان يمكن أن تساعد في علاج عسر الهضم على الرغم من عدم وجود أدلة مؤكدة على ذلك.

تقوية التركيز

يُعتقد أن رائحة حصى البان تُساعد على تقوية التركيز والذاكرة.

حماية الأعصاب

يُحتمل أن هذه العشبة تعمل على حماية الأعصاب من التلف، والمساعدة في التعافي من السكتات الدماغية، حيث يعود ذلك لاحتوائها على حمض الكرنوسيك (Carnosic acid).

الوقاية من مرض الزهايمر

من الممكن أن تُستخدم نبتة حصى البان في علاج الزهايمر مستقبلًا بسبب احتوائها على مركبات الديتريبين (Diterpenes)، التي تعمل كمضادات للأكسدة، ومضادات للالتهاب.

كما أنها تمنع تكون المادة التي يُعتقد أن تراكمها يسبب الزهايمر وهي البيتا أميلويد.

مكافحة السرطان

يُحتمل أن تساعد هذه العشبة في الإبطاء من انتشار خلايا سرطان الثدي وسرطان الدم، فهي مضادة للأورام ومضادة للالتهاب